Stoke Therapeutics · 20 hours ago
Senior Director, Learning & Development
Bedford, Massachusetts, United States
Full-time
Hybrid
Director/Executive
$256K/yr - $301K/yr
10+ years expStoke Therapeutics is a biotechnology company dedicated to restoring protein expression through RNA medicine. The Senior Director of Learning and Development will lead the design and execution of a comprehensive learning strategy, focusing on training infrastructure for medical and commercial teams to align with the company's objectives.
BiotechnologyHealth CarePharmaceuticalTherapeutics
Responsibilities
Build a comprehensive training strategy aligned with business objectives to enhance knowledge and skills on SMA and zorevunersen across U.S. and global markets
Lead and oversee medical and commercial training initiatives
Lead development initiatives, i.e., training, coaching, learning initiatives
Lead creation and standardization of Launch Excellence frameworks from early planning through post-launch sustainment
Design and train on learning solutions grounded in adult learning theory to maximize knowledge of retention and application
Oversee development and facilitation of dynamic workshops on disease states, products, market landscapes, and contextual selling skills for diverse audiences
Train and coach leaders for key conversations that drive team performance, instilling high confidence in the performance of team members, and ensuring employees receive balanced and actionable feedback
Partner with executive leaders to provide strategic guidance aligning people programs to business outcomes and while ensuring high employee engagement
Lead, evaluate and monitor training programs to ensure training objectives are being met
Ensure the appropriate utilization of resources by overseeing the identification and selection of vendors as well as existing relationships and projects relating to training
Design and implement practices ensuring continuous improvement of a high-performance culture
Other duties as assigned
Qualification
Required
Bachelor's degree in business, science or related field
10+ years of experience working in the pharmaceutical or biotech industry with 8+ years of experience in sales/commercial training
Ability to lead all medical affairs and commercial trainings
Experience leading development initiatives (i.e., training programs, feedback and evaluation, collaboration, LMS systems, career development, content creation, digital training assignments, performance consulting, learning analytics and facilitation and coaching)
Firm understanding and applicability of adult learning theory framework and experience with each of the adult learning modules (i.e., visual and spatial, auditory, linguistics, andragogical and experiential learning)
Experience using different learning methodologies
Strong interpersonal skills with demonstrated ability to drive toward consensus
Exceptional, persuasive, written, and verbal communication skills. Willingness to present the facts and put forth hypothesis in the face of differing opinions
Excellent presentation skills with the ability to establish logical flow and story. Experience presenting to senior management
Ability to adjust to changing needs within the organization and flexibility to change priorities as needed
Ability to self-direct projects and work independently
Ability to work cross functionally with key internal stakeholders including, but not limited to Sales, Market Access, Marketing and Human Resources
Demonstrated values-based skills and strong work ethic
Pharmaceutical launch experience with an emphasis on building infrastructure and processes from scratch
Preferred
A master's degree (MBA) is strongly preferred
Benefits
Medical, dental and vision insurance
Life, long- and short-term disability insurance
Paid parental leave
A 401K plan with company match
Unlimited vacation time
Tuition assistance
Participation in our Employee Stock Purchase Program (ESPP)
Company
Stoke Therapeutics
Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for treatment.
51-200 employees
Funding
Current Stage
Public CompanyTotal Funding
$360.1MKey Investors
Apple Tree Partners
2024-03-27Post Ipo Equity· $125M
2020-11-24Post Ipo Equity· $105.1M
2019-06-19IPO
Leadership Team
Edward Kaye
CEO & Founder
Adrian Krainer
Co-founder & Director
Recent News
BioWorld Financial Watch
2026-01-15
2026-01-13
2026-01-12
Company data provided by crunchbase